dc.contributor.author	Andrews, Caroline
dc.contributor.author	McLean, Mairi H
dc.contributor.author	Durum, Scott K
dc.contributor.institution	University of Aberdeen.Applied Medicine	en
dc.date.accessioned	2017-08-10T16:00:25Z
dc.date.available	2017-08-10T16:00:25Z
dc.date.embargoedUntil	2017-05-25
dc.date.issued	2016-09
dc.description	Conflicts of interest and source of funding: Drs Andrews and Durum are supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute. The authors have no conflicts of interest to disclose.	en
dc.description.status	Peer reviewed	en
dc.format.extent	10
dc.format.extent	433367
dc.format.extent	213658
dc.format.extent	210118
dc.format.extent	770173
dc.identifier	68924417
dc.identifier	a551219e-e281-4d9e-a325-96bef969d91f
dc.identifier	27243591
dc.identifier	84983656089
dc.identifier.citation	Andrews, C, McLean, M H & Durum, S K 2016, 'Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease : A Critical Review of the Literature', Inflammatory Bowel Diseases, vol. 22, no. 9, pp. 2255-2264. https://doi.org/10.1097/MIB.0000000000000818	en
dc.identifier.doi	10.1097/MIB.0000000000000818
dc.identifier.iss	9	en
dc.identifier.issn	1078-0998
dc.identifier.other	ORCID: /0000-0002-7443-2653/work/76974180
dc.identifier.uri	http://hdl.handle.net/2164/9122
dc.identifier.vol	22	en
dc.language.iso	eng
dc.relation.ispartof	Inflammatory Bowel Diseases	en
dc.subject	SDG 3 - Good Health and Well-being	en
dc.subject	Crohn’s disease	en
dc.subject	IBD	en
dc.subject	IL-27	en
dc.subject	ulcerative colitis	en
dc.subject	R Medicine	en
dc.subject.lcc	R	en
dc.title	Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease : A Critical Review of the Literature	en
dc.type	Journal item	en

Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease : A Critical Review of the Literature

Files

Original bundle

License bundle

Collections